DYRK2 and plasma cell myeloma: In this context, two DYRK2 inhibitors, the natural drug curcumin and the small-molecule LDN192960, impaired cell proliferation and invasion and induced apoptosis in multiple myeloma and TNBC cell lines [134,162].